Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127178141 | 12717814 | 1 | I | 20150729 | 20150730 | 20160906 | 20160906 | EXP | PL-PFIZER INC-2015256270 | PFIZER | 74.00 | YR | F | Y | 73.00000 | KG | 20160906 | MD | PL | PL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127178141 | 12717814 | 1 | PS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | 460 MG, EVERY 21 DAYS | Y | 76517 | 460 | MG | Q3W | ||||||
| 127178141 | 12717814 | 2 | SS | DOCETAXEL. | DOCETAXEL | 1 | Intravenous (not otherwise specified) | 106 MG, EVERY 21 DAYS | Y | 202356 | 106 | MG | Q3W | ||||||
| 127178141 | 12717814 | 3 | SS | TRASTUZUMAB | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | 456 MG, EVERY 3 WEEKS (EVERY 21 DAYS); MOST RECENT DOSE BEFORE THE EVENT: 20JUL2015 | 0 | 456 | MG | POWDER FOR SOLUTION FOR INFUSION | Q3W | ||||||
| 127178141 | 12717814 | 4 | SS | GLUCOPHAGE | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, 1X/DAY | 0 | 500 | MG | QD | |||||||
| 127178141 | 12717814 | 5 | C | EUTHYROX | LEVOTHYROXINE SODIUM | 1 | Oral | 40 MG, 1X/DAY | 0 | 100 | UG | QD | |||||||
| 127178141 | 12717814 | 6 | C | BIOSOTAL | 2 | Oral | 40 MG, 3X/DAY | 0 | 40 | MG | TID | ||||||||
| 127178141 | 12717814 | 7 | C | FLUANXOL | FLUPENTIXOL | 1 | Oral | 0.5 MG, 1X/DAY | 0 | .5 | MG | QD | |||||||
| 127178141 | 12717814 | 8 | C | ANAFRANIL | CLOMIPRAMINE HYDROCHLORIDE | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | QD | |||||||
| 127178141 | 12717814 | 9 | C | SORTIS | ATORVASTATIN | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | QD | |||||||
| 127178141 | 12717814 | 10 | C | KARBIS | CANDESARTAN CILEXETIL | 1 | Oral | 4 MG, 2X/DAY | 0 | 4 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127178141 | 12717814 | 1 | Breast cancer |
| 127178141 | 12717814 | 2 | Breast cancer |
| 127178141 | 12717814 | 3 | Breast cancer |
| 127178141 | 12717814 | 4 | Diabetes mellitus |
| 127178141 | 12717814 | 5 | Hypothyroidism |
| 127178141 | 12717814 | 6 | Arrhythmia |
| 127178141 | 12717814 | 7 | Depression |
| 127178141 | 12717814 | 8 | Depression |
| 127178141 | 12717814 | 9 | Hypercholesterolaemia |
| 127178141 | 12717814 | 10 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127178141 | 12717814 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127178141 | 12717814 | Hypokalaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127178141 | 12717814 | 1 | 20150518 | 0 | ||
| 127178141 | 12717814 | 2 | 20150518 | 0 | ||
| 127178141 | 12717814 | 3 | 20150518 | 0 | ||
| 127178141 | 12717814 | 4 | 20110101 | 0 | ||
| 127178141 | 12717814 | 5 | 20090101 | 0 | ||
| 127178141 | 12717814 | 6 | 20130101 | 0 | ||
| 127178141 | 12717814 | 7 | 20090101 | 0 | ||
| 127178141 | 12717814 | 8 | 19850101 | 0 | ||
| 127178141 | 12717814 | 9 | 20100101 | 0 | ||
| 127178141 | 12717814 | 10 | 20130101 | 0 |